secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avinger Inc (—)
CIK:        0001506928
Form:       8-K/A
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001437749-24-007182
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 3.03, 1.01, 5.03, 2.03, 3.02, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avinger enters strategic partnership with Zylox-Tonbridge; receives $7.5M initial investment
--------------------------------------------------------------------------------

- License Agreement for Avinger products in Greater China; 20-year initial term, mid-single to high-single digit royalty.
- Collaboration Agreement gives Avinger option to distribute Zylox-Tonbridge peripheral products in U.S. and Germany.
- Purchaser invested $7.5M for common shares and Series F preferred; potential $7.5M more on Milestones (FDA registration, $10M revenue).
- Jonathon Zhong Zhao appointed to Board as Class II director.
- Loan Amendment with CRG extends interest-only period to Dec 2026; interest may be paid in kind.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506928/000143774924007182/0001437749-24-007182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506928/000143774924007182/avgr20240308_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-007182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer